{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:00:34Z","timestamp":1791252034612,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.compbiolchem.2026.109003","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T20:52:01Z","timestamp":1773003121000},"page":"109003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Comparative in silico evaluation of selective and preferential COX-2 inhibitors: Insights from molecular docking, molecular dynamics, ADMET, and toxicity profiling"],"prefix":"10.1016","volume":"123","author":[{"given":"Abdalla Ali","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahez Ahmed","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zana Hassan","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Bahnam","family":"Abbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebaz Anwar","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roz Goran","family":"Abdlrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman Sleman","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109003_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/0091270003251122","article-title":"Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man","volume":"43","author":"Agrawal","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.compbiolchem.2026.109003_bib2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.matpr.2022.05.344","article-title":"Synthesis, ADMET, drug likeness and in silico activities of benzimidazole derivative","volume":"67","author":"Agrwal","year":"2022","journal-title":"Mater. Today. Proc."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109003_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s13369-021-05377-1","article-title":"Molecular docking and antibacterial studies of pyranopyrazole derivatives synthesized using [Pap-Glu@Chi] biocatalyst through a greener approach","volume":"47","author":"Agrwal","year":"2022","journal-title":"Arab. J. Sci. Eng."},{"key":"10.1016\/j.compbiolchem.2026.109003_bib4","series-title":"Bioinformatics in Veterinary Science: Vetinformatics","first-page":"277","article-title":"Molecular Docking and Virtual Screening to Investigate Lead Compounds for Veterinary Drug Development","author":"Agrwal","year":"2025"},{"issue":"14","key":"10.1016\/j.compbiolchem.2026.109003_bib5","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2174\/1381612053764904","article-title":"Gastrointestinal effects of selective and non-selective non-steroidal anti- inflammatory drugs","volume":"11","author":"Akarca","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.compbiolchem.2026.109003_bib6","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fchem.2024.1339891","article-title":"Integrating computational methods guided the discovery of phytochemicals as potential Pin1 inhibitors for cancer: pharmacophore modeling, molecular docking, MM-GBSA calculations and molecular dynamics studies","volume":"12","author":"Alzain","year":"2024","journal-title":"Front. Chem."},{"issue":"18","key":"10.1016\/j.compbiolchem.2026.109003_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202404555","article-title":"Exploring Riboflavin's antimicrobial potential against staphylococcus aureus: insights from molecular docking, dynamics, and quantum chemical studies","volume":"10","author":"Amin","year":"2025","journal-title":"ChemistrySelect"},{"issue":"W1","key":"10.1016\/j.compbiolchem.2026.109003_bib8","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109003_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/ars.2011.4408","article-title":"Eicosanoids and adipokines in breast cancer: from molecular mechanisms to clinical considerations","volume":"18","author":"Basu","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109003_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1517\/14656566.2.1.19","article-title":"Intelligent use of NSAIDs-where do we stand?","volume":"2","author":"Berger","year":"2001","journal-title":"Expert Opin. Pharmacother."},{"issue":"14","key":"10.1016\/j.compbiolchem.2026.109003_bib11","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1021\/jm100112j","article-title":"A medicinal chemist\u2019s guide to molecular interactions","volume":"53","author":"Bissantz","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109003_bib12","series-title":"Proceedings of the 2006 ACM\/IEEE conference on Supercomputing","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"},{"key":"10.1016\/j.compbiolchem.2026.109003_bib13","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3390\/ph17111488","article-title":"Exploring COX-independent pathways: a novel approach for meloxicam and other NSAIDs in cancer and cardiovascular disease treatment","volume":"17","author":"Cheng","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109003_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/004982598239704","article-title":"Metabolism of meloxicam in human liver involves cytochromes P4502C9 and 3A4","volume":"28","author":"Chesne","year":"1998","journal-title":"Xenobiotica"},{"issue":"18","key":"10.1016\/j.compbiolchem.2026.109003_bib15","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.2165\/00003495-200262180-00006","article-title":"Etoricoxib","volume":"62","author":"Cochrane","year":"2002","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109003_bib16","first-page":"96","article-title":"Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond","volume":"78","author":"Coruzzi","year":"2007","journal-title":"Acta Biomed."},{"issue":"18","key":"10.1016\/j.compbiolchem.2026.109003_bib17","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.2174\/0929867327999200917150939","article-title":"Natural COX-2 inhibitors as promising anti-inflammatory agents: an update","volume":"28","author":"Cui","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109003_bib18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109003_bib19","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109003_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00003088-199936020-00003","article-title":"Clinical pharmacokinetics of meloxicam","volume":"36","author":"Davies","year":"1999","journal-title":"Clin. Pharmacokinet."},{"issue":"9","key":"10.1016\/j.compbiolchem.2026.109003_bib21","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"Role of molecular dynamics and related methods in drug discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.compbiolchem.2026.109003_bib22","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2165\/00044011-200222120-00001","article-title":"Efficacy and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug","volume":"22","author":"Del Tacca","year":"2002","journal-title":"Clin. Drug Investig."},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109003_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000542-200502000-00026","article-title":"Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans","volume":"102","author":"Dembo","year":"2005","journal-title":"Anesthesiology"},{"issue":"_1","key":"10.1016\/j.compbiolchem.2026.109003_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/rheumatology\/35.suppl_1.4","article-title":"Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2","volume":"35","author":"Engelhardt","year":"1996","journal-title":"Br. J. Rheumatol."},{"issue":"32","key":"10.1016\/j.compbiolchem.2026.109003_bib25","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.2174\/092986710793205408","article-title":"Selective COX-1 inhibition: a therapeutic target to be reconsidered","volume":"17","author":"G Perrone","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"34","key":"10.1016\/j.compbiolchem.2026.109003_bib26","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.2174\/0929867323666160530144742","article-title":"Current tools and methods in molecular dynamics (MD) simulations for drug design","volume":"23","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109003_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1568007054038201","article-title":"The Role of COX-1 and COX-2 in Alzheimer's Disease Pathology and the Therapeutic Potentials of Non-Steroidal Anti-Inflammatory Drugs","volume":"4","author":"Hoozemans","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109003_bib28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/gut.47.6.762","article-title":"Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa","volume":"47","author":"Jackson","year":"2000","journal-title":"Gut"},{"issue":"18","key":"10.1016\/j.compbiolchem.2026.109003_bib29","doi-asserted-by":"crossref","DOI":"10.1063\/5.0193281","article-title":"Novel barostat implementation for molecular dynamics","volume":"160","author":"Janek","year":"2024","journal-title":"J. Chem. Phys."},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109003_bib30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-2044.2000.01271.x","article-title":"Cyclo-oxygenase isoenzymes: physiological and pharmacological role","volume":"55","author":"Kam","year":"2000","journal-title":"Anaesthesia"},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109003_bib31","first-page":"813","article-title":"Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitor","volume":"29","author":"Kassahun","year":"2001","journal-title":"Drug Metab. Dispos."},{"issue":"2-3","key":"10.1016\/j.compbiolchem.2026.109003_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/minf.201000151","article-title":"QSAR modelling of rat acute toxicity on the basis of PASS prediction","volume":"30","author":"Lagunin","year":"2011","journal-title":"Mol. Inform."},{"key":"10.1016\/j.compbiolchem.2026.109003_bib33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3390\/biom12101383","article-title":"Calcium-permeable channels cooperation for rheumatoid arthritis: therapeutic opportunities","volume":"12","author":"Liang","year":"2022","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109003_bib34","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nsb1196-927","article-title":"Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2","volume":"3","author":"Luong","year":"1996","journal-title":"Nat. Struct. Biol."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109003_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109003_bib36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00003088-200342060-00002","article-title":"Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges","volume":"42","author":"Masimirembwa","year":"2003","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109003_bib37","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1038\/s41598-021-83438-z","article-title":"Three-dimensional structure of human cyclooxygenase (hCOX)-1","volume":"11","author":"Miciaccia","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2026.109003_bib38","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.1004802","article-title":"Navigating the computational seas: a comprehensive overview of molecular docking software in drug discovery","author":"Mursal","year":"2024","journal-title":"Unravelling Mol. Docking Theory Pract."},{"issue":"10","key":"10.1016\/j.compbiolchem.2026.109003_bib39","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1107\/S2053230X16014230","article-title":"Crystal structure of rofecoxib bound to human cyclooxygenase-2","volume":"72","author":"Orlando","year":"2016","journal-title":"Acta Crystallogr. Sect. F."},{"key":"10.1016\/j.compbiolchem.2026.109003_bib40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/9781119830306.ch24","article-title":"Non-steroidal anti-inflammatory drugs","author":"Papich","year":"2024","journal-title":"Vet. Anesth. Analg. Sixth Ed. Lumb Jones"},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109003_bib41","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0090-9556(24)15094-5","article-title":"Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats","volume":"28","author":"Paulson","year":"2000","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.compbiolchem.2026.109003_bib42","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1021\/acs.jcim.9b00373","article-title":"Comprehensive assessment of torsional strain in crystal structures of small molecules and protein\u2013ligand complexes using ab initio calculations","volume":"59","author":"Rai","year":"2019","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109003_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00210-009-0482-0","article-title":"Absorption and distribution of etoricoxib in plasma, CSF, and wound tissue in patients following hip surgery\u2014a pilot study","volume":"381","author":"Renner","year":"2010","journal-title":"NaunynSchmiede 's. Arch. Pharmacol."},{"issue":"15","key":"10.1016\/j.compbiolchem.2026.109003_bib44","doi-asserted-by":"crossref","first-page":"7592","DOI":"10.1021\/acs.chemrev.0c00215","article-title":"Structural and chemical biology of the interaction of cyclooxygenase with substrates and non-steroidal anti-inflammatory drugs","volume":"120","author":"Rouzer","year":"2020","journal-title":"Chem. Rev."},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109003_bib45","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2036.2004.02092.x","article-title":"The hepatotoxicity of non-steroidal anti-inflammatory drugs","volume":"20","author":"Rubenstein","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109003_bib46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/cea.12697","article-title":"Cyclooxygenase 2: its regulation, role and impact in airway inflammation","volume":"46","author":"Rumzhum","year":"2016","journal-title":"Clin. Exp. Allergy"},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109003_bib47","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1021\/acs.biochem.7b01019","article-title":"Molecular mechanisms in the selectivity of nonsteroidal anti-inflammatory drugs","volume":"57","author":"Shamsudin","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.compbiolchem.2026.109003_bib48","series-title":"First Aid Perioperative Ultrasound: Acute Pain Manual for Surgical Procedures","first-page":"127","article-title":"Nonsteroidal Anti-inflammatory Drugs (NSAIDs)","author":"Sobhani","year":"2023"},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109003_bib49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0022-3565(24)39255-9","article-title":"Major Role of Human Liver Microsomal Cytochrome P450 2C9 (CYP2C9) in the Oxidative Metabolism of Celecoxib, a Novel Cyclooxygenase-II Inhibitor","volume":"293","author":"Tang","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109003_bib50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2174\/0115734099282836231212064925","article-title":"In-silico Design, ADMET Screening, Prime MM-GBSA Binding Free Energy Calculation and MD Simulation of Some Novel Phenothiazines as 5HT6R Antagonists Targeting Alzheimer\u2019s Disease","volume":"21","author":"Vediappan","year":"2025","journal-title":"Curr. Comput. Aided Drug Des."},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109003_bib51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/med.10065","article-title":"Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: Role in atherosclerosis","volume":"24","author":"Vila","year":"2004","journal-title":"Med. Res. Rev."},{"issue":"21","key":"10.1016\/j.compbiolchem.2026.109003_bib52","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1021\/jm901885s","article-title":"Direct renin inhibitors as a new therapy for hypertension","volume":"53","author":"Webb","year":"2010","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109003_bib53","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1021\/jm030912m","article-title":"Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib:\u2009new pharmacological opportunities due to related binding site recognition","volume":"47","author":"Weber","year":"2004","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.compbiolchem.2026.109003_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137113","article-title":"Exploring strong interactions in proteins with quantum chemistry and examples of their applications in drug design","volume":"10","author":"Xie","year":"2015","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109003_bib55","first-page":"655","article-title":"Selective COX-2 inhibitors: a review of their structure-activity relationships","volume":"10","author":"Zarghi","year":"2011","journal-title":"Iran. J. Pharm. Res"}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927126001283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927126001283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:27:24Z","timestamp":1778052444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927126001283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":55,"alternative-id":["S1476927126001283"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109003","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative in silico evaluation of selective and preferential COX-2 inhibitors: Insights from molecular docking, molecular dynamics, ADMET, and toxicity profiling","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109003"}}